Porcine Reproductive & Respiratory Syndrome roadmap:
Vaccines
Roadmap for development of a candidate vaccine for PRRSV
Download PRRSV Vaccine Roadmap1
Vaccine
Dependencies
- 4 Inactivated vaccines
- 4A Safety
- 4B Delivery route
- 4C Delivery platform
- 4D Efficacy in challenge model
- 5 DNA/RNA vaccines
- 5A Safety
- 5B Delivery route
- 5C Delivery platform
- 5D Efficacy in challenge model
- 6 Subunit vaccines
- 6A Safety
- 6B Delivery route
- 6C Delivery platform
- 6D Efficacy in challenge model
- 7 Vectored vaccines
- 7A Safety
- 7B Delivery route
- 7C Delivery platform
- 7D Efficacy in challenge model
An improved multivalent PRRSV vaccine preventing disease, virus transmission and carrier state in vaccinated animals
Research Question
- Protection against disease caused by the various virus strains
- Sterile immunity
- Prevent vaccine virus contributing to evolution of field isolates
- Virus eradication from a herd
Research Gaps and Challenges
- Cross-protection against the various isolates
- Attenuated live viruses can contribute to virus evolution
- Generation of both a CTC and VN response
- The dominant immunogens may not be protective
Solution Routes
- Establish protection levels with various candidate vaccine options, including priming with one vaccine and boosting with a different vaccine
- Establish if pig genetics influences responses
- Incorporate the candidate vaccine in a vaccine platform covering a number of diseases
- The development of farm strain-specific vaccines (autologous vaccines)
Dependencies
- Development of cross protective/multivalent killed vaccine
- Development of a cross protective/multivalent vectored vaccine
- Development of a subunit vaccine
- Development of an attenuated vaccine that does not persist or is excreted
Projects
What activities are planned or underway?
Immune responses induced by inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccine in neonate pigs using different adjuvants
Planned Completion date 01/02/2021
Source Countries:
Netherlands
Modified live vaccine strains of porcine reproductive and respiratory syndrome virus cause immune system dysregulation similar to wild strains.
Planned Completion date 12/01/2024
Source Countries:
Netherlands